The payer review and the R&D offsite both need executive judgment in the same hours.
The review protects confidence in reachable in-network care, while the offsite protects delivery decisions across Product and Engineering.
Who you’d be doing this for
“I finally found someone covered by my plan, and now their next opening keeps changing.”
Elias Salehi · Therapy-Seeking Patient
She is trying to book a covered therapy appointment and is affected when patient-access commitments lose momentum.
What is at stake
A payer review and an R&D offsite need the CPO and CTO during the same two-day window. You have to weigh credible payer participation against decisions that keep patient-access work moving.
Why it isn’t already fixed
Every obvious fix costs something else. That’s the part you’d have to decide.
- payer confidence vs. R&D decision continuity
- executive presence vs. preparation quality
- travel certainty vs. late-breaking access risk
- delegation speed vs. accountable authority
Why Headway
Accurate in-network access depends on R&D commitments staying intact while payer-facing obligations receive credible executive attention.
Written with these in mind
Not your kind of problem? 75 more at Headway, or browse every organization.
This is the setup. The work is inside.
Running it puts you in the room: the full situation and its constraints, stakeholders who push back in their own words, and the decisions that are yours to make. What you produce becomes a Day One Plan — work you can show someone instead of describing.